Neoplasms
📧 Sign up to get email alerts when something new happens for Neoplasms.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-05-08Clinical Trial Update: Integrative and Complementary Health Practices (PICS) [NA]
Clinical trial update for Integrative and Complementary Health Practices (PICS) shows a study currently recruiting for neoplasms and epileps…
-
CLINICAL_TRIALS trial_result · 2024-04-26Clinical Trial Update: Crossover Study to Assess the Relative Bioavailability and Bioequivalence of Niraparib Tablet Compared to Niraparib Capsule [Phase 1]
A Phase 1 crossover study evaluated the relative bioavailability and bioequivalence of niraparib tablets compared with niraparib capsules in…
-
CLINICAL_TRIALS trial_result · 2024-04-18Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Bintrafusp Alfa (M7824) Monotherapy in Metastatic or Locally Advanced Urothelial Cancer [Phase 1]
Phase 1 trial evaluating bintrafusp alfa (M7824) monotherapy in metastatic or locally advanced urothelial cancer has been terminated with re…
-
CLINICAL_TRIALS trial_result · 2024-04-15Clinical Trial Update: BI 894999 First in Human Dose Finding Study in Advanced Malignancies [Phase 1]
First-in-human Phase 1 dose-finding study of BI 894999 in advanced malignancies has completed; results posted.
-
CLINICAL_TRIALS trial_result · 2024-03-04Clinical Trial Update: This Study Aims to Find and Test a Safe Dose of BI 905677 in Patients With Different Types of Cancer (Solid Tumours) [Phase 1]
Phase 1 trial update for BI 905677 in various solid tumors; study terminated with results posted in 2024.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-02-12Clinical Trial Update: Study of TSR-033 With an Anti-programmed Cell Death-1 Receptor (PD-1) in Participants With Advanced Solid Tumors [Phase 1]
A Phase 1 study evaluating TSR-033 in combination with an anti-PD-1 therapy in participants with advanced solid tumors has been completed wi…
-
CLINICAL_TRIALS trial_result · 2024-02-07Clinical Trial Update: Evaluation Glizigen® and Ocoxin®-Viusid® in High-grade Cervical Intraepithelial Lesions [Phase 2]
Phase 2 clinical trial evaluation of Glizigen and Ocoxin-Viusid for high-grade cervical intraepithelial lesions is ongoing with an unknown s…
-
CLINICAL_TRIALS trial_result · 2024-02-07Clinical Trial Update: Anti-PD-1 Alone or Combined With Autologous DC-CIK Cell Therapy in Advanced Solid Tumors [Phase 1, Phase 2]
A phase 1/2 trial evaluating anti-PD-1 therapy alone or with autologous DC-CIK cell therapy in advanced solid tumors has completed.
-
CLINICAL_TRIALS trial_result · 2024-02-05Clinical Trial Update: Screening Protocol for Preliminary Eligibility Determination for Adoptive Cell Therapy Trials [Phase 2]
Phase 2 trial update describing a screening protocol for preliminary eligibility in adoptive cell therapy trials; study terminated with post…
-
CLINICAL_TRIALS trial_result · 2024-01-30Clinical Trial Update: A Study of TY-1091 in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
A Phase 1/2 clinical trial update for TY-1091 in patients with RET-altered solid tumors, including RET-altered non-small cell lung cancer an…
-
CLINICAL_TRIALS trial_result · 2023-11-29Clinical Trial Update: A Trial to Find the Safe Dose for BI 905681 in Patients With Incurable Tumours or Tumours That Have Spread [Phase 1]
A Phase 1 trial aimed at identifying a safe dose of BI 905681 in patients with incurable or metastatic tumours has completed with results po…
-
CLINICAL_TRIALS trial_result · 2023-11-18Clinical Trial Update: Exercise Intervention for LGBT Cancer Survivors [NA]
Clinical trial evaluating an exercise intervention for cancer survivors (LGBT-focused); study completed with results posted in 2023.
-
EMA approval · 2023-10-23EMA Authorised: Thiotepa Riemser (thiotepa) — Esteve Pharmaceuticals GmbH
EMA authorised Thiotepa Riemser for indications related to hematopoietic stem cell transplantation and neoplasms.
-
CLINICAL_TRIALS trial_result · 2023-10-10Clinical Trial Update: STUDY OF TALAZOPARIB MONOTHERAPY IN CHINESE PARTICIPANTS WITH ADVANCED SOLID TUMORS [Phase 1]
Phase 1 study of talazoparib monotherapy in Chinese participants with advanced solid tumors has completed; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-10-03Clinical Trial Update: BI 6727 Administered Intravenously Every 3 Weeks in Patients With Solid Tumours [Phase 1]
Phase 1 trial of BI 6727 given IV every 3 weeks in patients with solid tumours has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-09-01Clinical Trial Update: Investigation of Potential Drug-drug Interaction of Volasertib With Itraconazole in Patients With Various Tumours [Phase 1]
Phase 1 trial investigating potential drug-drug interaction between volasertib and itraconazole in patients with various tumors; completed w…
-
CLINICAL_TRIALS research · 2023-08-22Clinical Trial Update: Effect of Spironolactone in the Prevention of Anthracycline-induced Cardiotoxicity (SPIROTOX) [Phase 4]
A Phase 4 trial evaluating whether spironolactone can prevent cardiotoxicity caused by anthracycline chemotherapy.
-
CLINICAL_TRIALS trial_result · 2023-08-09Clinical Trial Update: A Study of ARGX-110 in Participants With Advanced Malignancies [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating ARGX-110 in participants with advanced malignancies has completed.
-
CLINICAL_TRIALS trial_result · 2023-08-07Clinical Trial Update: A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors [Phase 2]
Phase 2 trial evaluating alectinib for locally-advanced or metastatic ALK-positive solid tumors; study terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2023-06-08Clinical Trial Update: Safety, Preliminary Efficacy and PK of Isatuximab (SAR650984) Alone or in Combination With Atezolizumab in Patients With Advanced Malignancies [Phase 1, Phase 2]
Phase 1/2 trial evaluating safety, preliminary efficacy, and pharmacokinetics of isatuximab alone or with atezolizumab in advanced malignanc…
-
CLINICAL_TRIALS trial_result · 2023-05-31Clinical Trial Update: A Dose Escalation With Expansion Study of EMB-01 in Participants With Advanced/Metastatic Solid Tumors [Phase 1, Phase 2]
A dose-escalation with expansion study of EMB-01 in advanced/metastatic solid tumors is underway across Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2023-02-01Clinical Trial Update: Pharmacokinetic and Pharmacodynamic Evaluation of Formulations of Δ9-THC [Phase 1, Phase 2]
Phase 1/2 trial evaluating pharmacokinetics and pharmacodynamics of different Δ9-THC formulations for nausea, vomiting, and cancer-related p…
-
CLINICAL_TRIALS trial_result · 2023-01-30Clinical Trial Update: Asses the Impact of Early Starting Erythropoetin in the Reduction of Transfusions Blood in Childrens [Phase 3]
Phase 3 trial assessing whether early erythropoietin reduces transfusion needs in pediatric patients with anemia, including neoplasms and ch…
-
CLINICAL_TRIALS trial_result · 2022-11-28Clinical Trial Update: Letetresgene Autoleucel Engineered T Cells in NY-ESO-1 Positive Participants With Advanced Myxoid/ Round Cell Liposarcoma [Phase 2]
Phase 2 trial of Letetresgene Autoleucel (engineered T cells) in NY-ESO-1 positive advanced myxoid/round cell liposarcoma has completed with…
-
CLINICAL_TRIALS trial_result · 2022-09-01Clinical Trial Update: Sorafenib Long Term Extension Program [Phase 3]
A Phase 3 long-term extension trial update for sorafenib in neoplasms has completed with results posted.